Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
37 studies found for:    Open Studies | "Chorea"
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Chorea"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Open Label Extension Study To Investigate Long Term Safety, Tolerability And Efficacy Of Pf-02545920 In Subjects With Huntington's Disease Who Completed Study A8241021
Condition: Huntington's Disease
Intervention: Drug: 20 mg BID of PF-02545920
2 Recruiting Botulinum Toxin for the Treatment of Involuntary Movement Disorders
Conditions: Chorea;   Drug Induced Dyskinesia;   Movement Disorder;   Muscular Disease;   Tic Disorder
Intervention: Other: Botulinum Toxin
3 Recruiting Deep Brain Stimulation (DBS) of the Globus Pallidus (GP) in Huntington's Disease (HD)
Condition: Huntington Disease
Intervention: Device: ACTIVA® PC neurostimulator (Model 37601)
4 Available Compassionate Use of Tetrabenazine in the Treatment of Abnormal Movements
Condition: Hyperkinetic Movement Disorders
Intervention: Drug: tetrabenazine
5 Recruiting Follow-up Measurement of Brain PDE10A Enzyme Levels in Huntington´s Disease Gene Expansion Carriers
Condition: Huntington's Disease
Intervention: Radiation: Radioligand [18F]MNI-659
6 Not yet recruiting FuRST 2.0 Cognitive Pre-Testing
Condition: Huntington's Disease
Intervention: Behavioral: FuRST 2.0
7 Not yet recruiting HDClarity: a Multi-site Cerebrospinal Fluid Collection Initiative to Facilitate Therapeutic Development for Huntington's Disease
Condition: Huntington's Disease
Intervention:
8 Not yet recruiting Safety Evaluation of Cellavita HD Administered Intravenously in Participants With Huntington's Disease
Condition: Huntington Disease
Interventions: Other: Cellavita HD lower dose;   Other: Cellavita HD intermediate dose;   Other: Cellavita HD Higher dose
9 Recruiting Dynamic Neuroimaging Biomarkers in Huntington's Disease
Condition: Brain Neuroimaging Biomarkers in Huntington Disease
Intervention:
10 Recruiting Feasibility of a Video-oculography in Patients With Huntington's Disease VOG-HD Study
Condition: Huntington Disease
Intervention: Device: Eye-tracking
11 Not yet recruiting Functional Imaging of Social Cognition in Premanifest Huntington's Disease
Condition: Huntington's Disease
Intervention: Other: functional Imaging
12 Recruiting Social Cognition in Huntington's Disease: Cognitive Study and Functional and Morphological Imaging
Condition: Huntington's Disease
Interventions: Behavioral: neuropsychological test;   Radiation: MRI
13 Recruiting Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of IONIS-HTTRx in Patients With Early Manifest Huntington's Disease
Condition: Huntington's Disease
Interventions: Drug: IONIS HTTRx;   Drug: Placebo
14 Recruiting A Pilot Study Assessing Impulsivity in Patients With Huntington's Disease on Xenazine (Tetrabenazine)
Condition: Huntington's Disease
Intervention: Drug: Tetrabenazine
15 Recruiting Tolerability, Safety, and Activity of SRX246 in Irritable Subjects With Huntington's Disease
Conditions: Irritable Mood;   Huntington's Disease
Interventions: Drug: SRX246;   Drug: Placebo
16 Recruiting A Comparative Phase 2 Study Assessing the Efficacy of Triheptanoin, an Anaplerotic Therapy in Huntington's Disease
Condition: Huntington Disease
Interventions: Drug: Triheptanoin oil;   Drug: Placebo
17 Recruiting Resveratrol and Huntington Disease
Condition: Huntington Disease
Interventions: Dietary Supplement: Resveratrol;   Other: Placebo
18 Not yet recruiting PINS Stimulator System for Deep Brain Stimulation in Huntington's Disease
Condition: Huntington's Disease
Intervention: Device: Deep Brain Stimulation
19 Recruiting A Clinical Study in Subjects With Huntington's Disease to Assess the Efficacy and Safety of Three Oral Doses of Laquinimod
Condition: Huntington's Disease
Interventions: Drug: Laquinimod;   Drug: Placebo
20 Recruiting Assessment of the Psychological, Cognitive and Social Resources of Applicants for Huntington's Disease and Presymptomatic Genetic Testing
Condition: Presymptomatic Huntington Disease
Interventions: Behavioral: psychological interview;   Radiation: MRI;   Other: cognitive tests;   Other: neurological tests

   Previous Page Studies Shown (1-20) Next Page (21-37) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.